Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Announces Quarterly Earnings Results, Misses Estimates By $0.10 EPS

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) posted its quarterly earnings data on Tuesday. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.10), Zacks reports. Bayer Aktiengesellschaft had a positive return on equity of 16.46% and a negative net margin of 2.02%. The business had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft updated its FY 2024 guidance to 5.610-6.045 EPS.

Bayer Aktiengesellschaft Price Performance

OTCMKTS:BAYRY opened at $5.41 on Friday. Bayer Aktiengesellschaft has a 1-year low of $5.33 and a 1-year high of $11.33. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.27 and a quick ratio of 0.86. The firm has a fifty day simple moving average of $7.39 and a 200 day simple moving average of $7.42.

Analysts Set New Price Targets

Separately, Bank of America upgraded shares of Bayer Aktiengesellschaft from an “underperform” rating to a “neutral” rating in a research note on Friday, September 6th. One research analyst has rated the stock with a sell rating and seven have given a hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold”.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.